Discover 93 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 93
Active & Responsive
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
for
Recurrent Endometrial Carcinoma,
Location: Great Falls MT, Anaconda MT, Bozeman MT, Missoula MT,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05554328
Phase2, Recruiting
Active & Responsive
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Great Falls MT, Bozeman MT, Missoula MT, Kalispell MT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Active & Responsive
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Great Falls MT, Missoula MT, Kalispell MT, Kelowna,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase3, Recruiting
Active & Responsive
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Great Falls MT, Havre MT, Anaconda MT, Bozeman MT,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
New
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Get alerts for new trials in your area by subscribing now
New
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Great Falls MT, Missoula MT, Billings MT, Sandpoint ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Great Falls MT, Anaconda MT, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Great Falls MT, Anaconda MT, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Great Falls MT, Missoula MT, Billings MT,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence
for
Stress Urinary Incontinence (SUI)
Location: Great Falls MT, Boise ID, Las Vegas NV, Phoenix AZ,